ISY BIO
ActiveSummary
ISY BIO has been active since 2015 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €368,785 and a net result of €166,232. Equity is growing by about 15% per year across the filed financial years. Its solvency ranks better than 36% of 9,624 sector peers (NACE 82, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
History
Acts, filings and financial milestones
30-11
Gazette deed
Reappointment: ISOARD Julien (director)Capital conversion · Amendment of the articles · Capital7 facts ▸
- General meeting, 27-11-2023
- Capital conversion, “Autre apport disponible hors capital” (deed in French)
- Amendment of the articles
- Capital
- Other provision, “cessions et transmissions d'actions, Article 9” (deed in French)
- Registered office clause, “7021 Havré, rue Georges Mabile 24” (deed in French)
- Director reappointment, ISOARD Julien (director (not named in the articles))
Show earlier events
About the unread acts
Of the 3 Belgian Official Gazette deeds we know for this company, 1 has been read. The other 2 have not been read yet: what they contain is neither established nor disproved here.